Beschouw je diabetes als een gevolg van te veel suiker (bijna 40 kg per jaar per persoon) en te weinig beweging, dan vergeet je nog een cruciale factor: de advanced glycation endproducts (AGEs). AGEs ontstaan in het lichaam en vormen de link tussen hyperglycemie en diabetescomplicaties. Kennis van de glycatie-scheikunde biedt interessante perspectieven in de natuurlijke strijd tegen AGEs.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Trefwoorden:
Figuren
Verschenen in
Referenties
1. Suji G, Sivakami S. Glucose, glycation and aging. Biogerontology 5: 365–373, 2004
2. Webster J, Urban C et al. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res. 2005;7(1-2):95-101
3. Ihl R, Perisic I, Maurer K, Dierks T 1989 Effect of 3 months treatment with tenilsetam in patients suffering from dementia of Alzheimer type (DAT). J Neural Transm 1:84–85
4. Hiroyuki Shoda, Satoshi Miyata et al. Inhibitory Effects of Tenilsetam on the Maillard Reaction. Endocrinology. 1997; 138(5): 1886-1892
5. Friedman Eli A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Proceedings from an Official Satellite Symposium of the 16th International Diabetes Federation Congress
6. Chi-Hao Wu, Shang-Ming Huang, Gow-Chin Yen. Antioxidants & Redox Signaling. February 1, 2011, 14(3): 353-366. doi:10.1089/ars.2010.3134.
7. Ahmad MS, Pischetsrieder M et al. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts. Eur J Pharmacol. 2007 Apr 30;561(1-3):32-8
8. Krone CA, Ely JTA. Ascorbic acid, glycation, glycohemoglobin and aging. Medical Hypotheses (2004) 62, 275-279
9. Babu PV, Sabitha KE et al. Therapeutic effect of green tea extract on advanced glycation and cross-linking of collagen in the aorta of streptozotocin diabetic rats. Clin Exp Pharmacol Physiol. 2006 Apr;33(4):351-7
10. Krajcovicova-Kudlackkova M et al. Advanced Glycation End Products and Nutrition. Physiol Res. 51: 313-316, 2002
11. Xanthis A, Hatzitolios A et al. Advanced Glycosylation End Products and Nutrition—A Possible Relation with Diabetic Atherosclerosis and How to Prevent It. Journal of food science. 2007; 72:R125-29
12. Effect of a "Fast Food" Diet on the Urinary Excretion of Maillard Reaction Products. Czech J Food Sci. 2009; 27:S160-S162
13. Vinson JA, Howard TB. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. Nutritional Biochemistry. 7:659-663, 1996
14. Busch M, Göbert A et al. Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease. Nephron Clin Pract. 2010;114(1):c38-46. Epub 2009 Oct 9
15. Vlassara H. Advanced glycation in health and disease: role of the modern environment. Ann N Y Acad Sci. 2005 Jun;1043:452-60. Review.
16. Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathologie Biologie 54 (2006) 405-419
17. Lapolla A et al. Advanced glycation end products/peptides - An in vivo investigation. Ann NY Acad Sci. 2005; 1043: 267-275
18. Brownson C, Hipkiss RA. Carnosine reacts with a glycated protein. Free Radical Biology & Medicine, Vol. 28, No. 10, pp. 1564-1570, 2000
19. Hipkiss AR. Would carnosine or a carnivorous diet help suppress aging and associated pathologies? Ann NY Acad Sci. 1067: 369-374 (2006)
20. Gariballa SE, Sinclair AJ. Carnosine: physiological properties and therapeutic potential. Age and Ageing 2000; 29: 207-210
21. Hipkiss AR. On the enigma of carnosine’s anti-ageing actions. Experimental Gerontology 44 (2009) 237-242
22. Boldyrev AA, Stvolinsky SL et al. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation research. 2010; 13(2-3):156-158
23. Williams ME, Bolton WK et al. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol. 2007;27(6):605-14. Epub 2007 Sep 6
24. Busch M, Göbert A et al. Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease. Nephron Clin Pract. 2010;114(1):c38-46. Epub 2009 Oct 9.
25. Thornalley, P. J. The potential role of thiamine (vitamin B1) in diabetic complications. Curr. Diabetes Rev. 1, 287–298 (2005).
26. Vallianou N, Evangelopoulos A et al. Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud. 2009 Winter;6(4):230-6. Epub 2009 Dec 30.
27. Moloney MA, Casey RG et al. Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics. Diab Vasc Dis Res. 2010 Oct;7(4):300-10. Epub 2010 Jul 28
28. Saraswat M, Reddy PY et al. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. Br J Nutr. 2009 Jun;101(11):1714-21. Epub 2008 Nov 6.
29. Kumar PA, Reddy PY et al. Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of alpha-crystallin chaperone activity. J Nutr Biochem. 2009 Jul;20(7):553-62. Epub 2008 Sep 11
30. Saraswat M, Suryanarayana P et al. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol Vis. 2010 Aug 10;16:1525-37
31. Pietraszek A, Gregersen S et al. Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis. 2010 Jun;20(5):366-75
32. Peppa M, Stavroulakis P, Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 2009 Jul-Aug;17(4):461-72
